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Abstract
Background—Atrial fibrillation (AF) is an important risk factor for stroke and overall mortality
but information about the preventable burden of AF is lacking. The aim of this study was to
determine what proportion of the burden of AF in African-Americans and whites could
theoretically be avoided by the maintenance of an optimal risk profile.
Methods and Results—This study included 14,598 middle-aged, Atherosclerosis Risk in
Communities Study cohort members. Previously established AF risk factors, namely high blood
pressure, elevated body mass index, diabetes, cigarette smoking and prior cardiac disease were
categorized into ‘optimal’, ‘borderline’ and ‘elevated’ levels. Based on their risk factor levels,
individuals were classified into one of these three groups. The population attributable fraction of
AF due to having a non-optimal risk profile was estimated separately for African-American and
white men and women.
During a mean follow-up of 17.1 years, 1520 cases of incident AF were identified. The age-
adjusted incidence rates were highest in white men and lowest in African-American women (7.45
and 3.67 per 1000 person-years, respectively). The overall prevalence of an optimal risk profile
was 5.4% but this varied according to race and gender: 10% in white women versus 1.6% in
African-American men. Overall, 56.5% of AF cases could be explained by having ≥ 1 elevated
risk factors, of which elevated blood pressure was the most important contributor.
Conclusions—As with other forms of cardiovascular disease, more than half of the AF burden
is potentially avoidable through the optimization of cardiovascular risk factors levels.
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Atrial fibrillation (AF) is one of the most commonly diagnosed cardiac arrhythmias in
clinical practice, affecting 2.3 million people in the United States (US) 1. Individuals with
AF are at substantially increased risk of stroke, and have twice the mortality rate from
cardiovascular disease (CVD) and overall compared with those with normal sinus
rhythm 2,3. Moreover, AF is responsible for one-third of all hospitalizations for cardiac
rhythm disturbances and consequently is associated with significant health care costs that in
the US alone exceed $6 billion annually 4.
Aside from age, established risk factors for AF include prior cardiac disease and raised
blood pressure (BP), and to a lesser extent, type-2 diabetes, obesity and cigarette smoking 5.
Hence, because of the aging US population, combined with both improved survival rates
after a coronary event and increasing mean population levels of diabetes and obesity, the
number of AF cases is expected to increase to 6-12 million by 2050 1,6.
Compared with coronary heart disease (CHD), heart failure (HF) and stroke, where it has
been estimated that 65 - 90% of events are potentially avoidable through maintaining
“optimal” cardiovascular risk factors levels 7,8, it is presently unknown what fraction of AF
is potentially avoidable by a similar optimization of pertinent risk factor levels. Moreover,
given that the relationships between risk factors and cardiovascular events are largely
continuous 9 and that the majority of the population, and hence events, tend to occur within
individuals displaying “borderline” as opposed to “elevated” risk factor levels 10,
consideration of the impact of having a borderline risk factor profile is also merited. The
Atherosclerosis Risk in Communities (ARIC) Study provides an ideal opportunity to study
the association between risk factor profile and the incidence of AF in both whites and
African-Americans 11.
METHODS
Study design and subjects
The ARIC Study is a prospective cohort study of atherosclerotic diseases within four
communities in the United States: Forsyth County, North Carolina; Jackson, Mississippi;
Washington County, Maryland; and the northwest suburbs of Minneapolis, Minnesota. The
recruitment of study participants is described in detail elsewhere 11. Briefly, the cohort
comprised at baseline in 1987-89, 15 792 men and women aged 45 – 64 years who were
selected by list of area probability sampling. The baseline home interview and clinic
examination measured various risk factors and cardiovascular conditions. Three triennial
study visits occurred subsequently with the last visit in 1996-98. Additionally, participants
or their proxy were contacted annually by telephone to ascertain hospitalizations and death.
The ARIC Study protocol was approved by the institutional review board of each
participating university and informed consent was obtained from each study participant.
Definition of exposure categories
Based on previous evidence we categorized individuals as having an optimal AF risk factor
profile if at baseline they met the following criteria 5,12-14: no history of cardiac disease (HF
or CHD); systolic blood pressure (SBP) < 120 mmHg and diastolic BP (DBP) < 80 mmHg
and no use of antihypertensive medication; body mass index (BMI) < 25 kg/m2; fasting
serum glucose (FSG) < 100 mg/dL and no use of anti-diabetic medication and no history of
physician-diagnosed diabetes; and never smoker. A borderline risk factor profile was
defined as having any of the following criteria and no elevated risk factor profile
characteristics (see below): SBP 120 - 139 mmHg and/or DBP 80 - 89 mmHg, and no use of
antihypertensive medication; BMI 25 -< 30 kg/m2; FSG 100-125 mg/dL and no use of anti-
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diabetic medication and no history of physician-diagnosed diabetes; and former smoker. An
elevated risk factor profile was defined as having any of the following criteria: history of
cardiac disease (HF or CHD); SBP ≥ 140 mmHg or DBP ≥ 90 mmHg or use of
antihypertensive medication; BMI ≥ 30 kg/m2; FSG ≥126 mg/dL or use of anti-diabetic
medication or history of physician-diagnosed diabetes; or current smoker.
Baseline examination
Blood collection and processing techniques have been previously described. In brief, serum
glucose was measured by a hexokinase/glucose-6-phosphate dehydrogenase method 15.
Sitting BP was measured three times using a random-zero sphygmomanometer after 5
minutes of rest. The mean of the last two measurements were used for the analysis. Self-
reported use of antihypertensive medications within the past two weeks was collected at
baseline. Smoking status (current, former or never smokers) was derived from interviews.
BMI (kg/m2) was computed from weight in a scrub suit and standing height. The primary
analysis was conducted in all individuals without a history of AF and a secondary analysis
was conducted after exclusion of individuals with prevalent CHD and heart failure at
baseline. Prevalent CHD included individuals with a history of myocardial infarction (MI),
MI adjudicated from the baseline ECG, or history of coronary bypass or angioplasty 15.
Prevalent heart failure (HF) cases were identified if any of the two conditions as follows was
true 16,17: a “yes” in response to the question “Were any of the medications you took during
the last 2 weeks for heart failure?”; presence of stage 3 or ‘manifest HF’ as defined using the
Gothenburg criteria 16. All current medications (taken within the preceding two weeks) were
brought into the clinic and documented.
Outcome Ascertainment
Individuals with evidence of AF or atrial flutter on an electrocardiogram (ECG) at study
baseline were excluded from this analysis. Diagnoses of incident AF and atrial flutter were
obtained through the end of 2007 from three sources: ECGs done at study visits (visits 2 –
4), presence of an International Classification of Disease (ICD9) code for AF (427.31 or
427.32) in a hospital discharge, or AF listed as any cause of death on a death certificate.
Hospitalizations with AF associated with open cardiac surgery were not considered events.
Date of AF incidence was the earliest of any AF diagnosis. All ARIC examination ECGs
were recorded using MAC PC Personal Cardiographs (Marquette Electronics, Inc,
Milwaukee, WI). A standard supine 12-lead resting ECG was recorded at each clinic visit
and was transmitted by modem to the ARIC ECG Reading Center for automatic reading and
coding. All AF cases that were automatically detected from the study ECGs were visually
rechecked by a cardiologist 15. Prior analysis within the ARIC cohort to determine the
validity of hospital discharge diagnoses for AF reported 84% sensitivity and 98% specificity
in the ascertainment of AF events 18.
Statistical analysis
Of the 15,792 initial ARIC participants, 1194 were excluded for the following reasons: non-
white and non-African-American (n = 48); prevalent AF or atrial flutter (n = 37); no ECG or
unreadable at baseline (n = 243); non-fasting blood sample (n = 592); missing covariates (n
= 274). Means and standard deviations (SD) for the baseline continuous variables and
percentages for the categorical variables were calculated separately for men and women and
for whites and African-Americans.
Age- and gender-standardized prevalence of optimal, borderline and elevated risk factors
were determined at study baseline (1987-89). The age- and gender-adjusted incidence of AF
by levels of optimal risk factors were estimated separately in whites and African-Americans
using Poisson regression. Person-years of follow-up were derived from the baseline
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examination until a first diagnosis of AF, loss to follow-up, death, or else until Dec 31,
2007. Associations of risk factor profile at baseline with the incidence of AF were estimated
using Cox proportional hazards models that were adjusted for age, study site, education,
income and height. Race and gender-specific analyses were conducted. The assumption of
proportional hazards was examined by adding to the model an interaction term between
follow-up time and exposure of interest, computing Schoenfeld residuals, and by inspection
of the log(- log[survival function]) curves. A SAS macro developed by Zhang and
colleagues 19 was used to estimate direct adjusted survival curves for each race/gender
category, based on a stratified Cox model.
Population attributable fractions (PAFs) were calculated to determine the possible impact of
altering risk profiles on AF occurrence. PAFs were computed according to the following
formula 20:
where pdi is the proportion of cases falling into ith exposure level and RRi is the relative
risk comparing ith exposure level with unexposed group (i=0). Poisson models were used to
obtain the RR. To estimate the PAFs for each of the five risk factors, models were adjusted
for age, study site, education, income, height and additionally for each of the other risk
factors under investigation (i.e. SBP, BMI, diabetes and smoking). One thousand bootstrap
samples were created to obtain the 95% confidence intervals for PAFs.
RESULTS
Prevalence of risk categories by race and gender
At baseline, the mean age (SD) of the 14 598 (55% female; 25% African-American)
participants included in this analysis was 54.2 years (5.8). Table 1 shows both the race- and
gender-specific prevalence of optimal, borderline and elevated levels of blood pressure,
BMI, diabetes, smoking and prior cardiac disease at study baseline.. Overall, just over 5% of
the cohort had optimal risk factor levels, just over one-quarter had one or more borderline
risk factor levels and two-thirds of the cohort had one or more elevated risk factors at study
baseline (Table 2). Over 80% of African-Americans had one or more elevated risk factors
compared with approximately 60% in whites.
Incidence of atrial fibrillation
During a mean follow-up of 17.1 years there were 1520 cases of incident AF. Of these,
98.8% were identified from hospitalizations, 7.8% from study ECGs, and 5.5% from death
certificates (some cases were identified by more than one method). The age-adjusted
incidence rates were 7.45, 4.59, 5.27 and 3.67 per 1000 person-years in white men, white
women, African-American men and African-American women, respectively. Compared
with those with no risk factors, the age-adjusted incidence rates were three times higher in
those with one or more elevated risk factors: 2.19 versus 6.59 per 1000 person years,
respectively (Table 3). Individuals with one or more borderline risk factor levels had
intermediate incidence rates. For any category of risk factor levels, white men had the
highest rates and African-American women the lowest (Table 3). Overall, among individuals
exhibiting an optimal risk factor profile the multiple-adjusted relative hazard (RH) (95% CI)
of AF was 0.33 (0.23 – 0.47) and in those with one or more borderline risk factors it was
0.50 (0.44 – 0.57) compared with those with one or more elevated risk factors. These
estimates were comparable across the four race and gender groups (Table 3). The gender and
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race-specific survival curves for the time spent free from AF according to risk factor profile
are shown in Figure 1 (a-d). In a sensitivity analysis that included only those individuals
who had their AF diagnosed at a study visit (n = 119), 25 cases of AF occurred among those
with a borderline risk factor profile and 94 occurred in those with an elevated risk factor
profile (no events occurred in the optimal risk profile group). The relative hazard (95% CI)
for having a borderline risk factor profile compared with having an elevated risk profile was
0.56 (0.36 to 0.87).
Overall, the PAF estimates indicated that having one or more elevated risk factor levels
could explain 50% (95% CI 37.5 to 58.5%) of AF events (Table 3). In whites, the PAF
estimates were comparable in women and men: 50% and 38.2%, respectively. In African-
Americans, the PAF estimates associated with having one or more elevated risk factors were
94% and 91% in women and men, respectively. However, this PAF estimate is subject to
considerable variability due to small numbers in the optimal risk factor category (n = 83),
and an alternative estimate based on the RR in the total population of whites and African-
Americans and the risk factor prevalence in African-Americans yielded a PAF of 49.4% in
African-American men and 59.5% in women (Table 3). Borderline levels of risk factors
explained an additional 6.5% of all AF cases. Thus, the proportion of all AF cases that could
be explained by having one or more borderline or elevated risk factor levels ranged from
44% in white men to 61% in African-American women (Table 3). After exclusion of those
1412 individuals with a prior history of cardiac disease at baseline, the overall percentage of
AF incident cases that could be attributed to one or more elevated and borderline risk factors
was reduced to 59.8%, 46.6%, 49.7% and 36.6% in African-American women, African-
American men, white women and white men, respectively.
Examination of the PAFs associated with each of the five risk factors in turn indicated that
elevated blood pressure, which affected 38.7% of the entire cohort, was the most important
contributor accounting for 21.6% (95% CI: 16.8 to 26.7%) of incident AF cases. This rose to
24.5% if borderline levels of blood pressure, which affected a further 22.7% of the cohort,
were also included (Table 4). Obesity and overweight explained 17.9% of all AF cases and
diabetes and impaired glucose tolerance combined, accounted for the smallest fraction of the
AF burden in this cohort (3.9%; Table 4).
DISCUSSION
Overall, in this US cohort of middle-aged adults who had been followed prospectively for,
on average, 17 years, 57% of incident AF (95% confidence interval 38% - 70%) could be
attributed to elevated or borderline levels of risk factors for AF namely: elevated blood
pressure, overweight/obesity, diabetes, smoking and prior cardiac disease. The PAF
estimates were broadly consistent across the race and gender groups although they were
slightly higher for African-Americans than for whites, in part, reflecting the greater
prevalence of underlying risk factors in African-Americans. It is also possible that the PAF
in African-Americans was underestimated. As explained previously, if the race-specific
estimates had been used, then all of the AF burden in African-Americans would have been
explained by having one or more borderline or elevated risk factors. But given that there
were no events within those African-Americans with an optimal risk profile the variability
around this estimate was considered to be too substantial to be meaningful. Hence, it was
considered more appropriate to use risk estimates from the total-population, as opposed to
race-specific risk estimates.
This is only the second study to attempt to quantify the burden of AF due to major and
modifiable risk factors. The previous study was based on the Framingham cohort which
reported that combined, cigarette smoking, diabetes, hypertension and prevalent CHD
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explained 44% of the burden in men and 58% in women.13 These estimates are broadly
comparable with those of the current study, which also sought to quantify the burden of AF
due to having borderline, rather than elevated, levels of risk factors. This is an important
consideration given that a significant proportion of the population has suboptimal levels of
BMI, blood pressure and blood glucose. In addition, we provide estimates for both whites
and African-Americans.
Elevated blood pressure was the most important contributor to the burden of AF. It
explained more than one-fifth of all AF cases and nearly one-quarter if borderline blood
pressure was also included. In comparison, only 3% of AF cases were attributable to
diabetes, which in part reflects the much higher prevalence of elevated blood pressure in the
study cohort (38.7%) compared with diabetes (10.1%). The current finding that elevated
levels of risk factors explained 50% of the overall incidence of AF in the ARIC cohort is
lower than previously reported ARIC estimates of the PAF for heart failure and CHD and
stroke (63.6% and 70.2% due to non-optimal risk factor levels, respectively) 7,8 suggests
that other factors, possibly genetic, may have a greater role in the etiology of AF. Indeed,
studies have indicated that the heritability component of AF is larger than it is for either
heart failure or coronary artery disease: 62% versus 28% versus 50%, respectively 21-23. It is
also possible that the PAFs estimated in the current study may actually have underestimated
the contribution of individual risk factors, such as obesity to the incidence of AF. Obesity
may increase the risk of AF through several different physiological pathways, for example,
by increasing the risk of diabetes or hypertension that in turn increase the risk of AF.
However, the model used in the current study only estimated the direct, and independent,
contribution of obesity on subsequent risk of AF and did not take into account the possible
indirect pathways by which obesity may impact on future risk of AF.
Potential for primary prevention
From a public health perspective our data highlight the substantial potential for AF risk
reduction through primary prevention strategies that target modification and improvement in
behavioral (e.g. cigarette smoking, sedentary lifestyle) and dietary risk factors (e.g. salt
intake, excess calorie consumption). Moreover, as improvement in these behaviors would
also impact favorably on other AF risk factors such as diabetes and impaired glucose
tolerance, the reduction in incidence of AF would be even greater than that expected through
blood pressure lowering alone. However, it should be noted that the current PAF estimates
refer only to the avoidance, rather than the reversal, of suboptimal levels of risk factors in
individuals with, for example, a history of obesity, hypertension or diabetes. In such
individuals, it is possible that long-term exposure to the effects of these morbidities may
cause irreversible damage to the atrium. Consequently, the risk of AF may remain elevated
in such individuals, even if levels of risk factors were to be normalized.
Possible explanations for racial disparity in incidence rates of AF
Individuals exhibiting an optimal risk profile had one-third the incidence rate of AF
compared with those with elevated risk factors. The rates at each risk profile were markedly
lower in African-Americans than in whites, especially men. The reasons for this racial
difference are unknown but unlikely to be explained by differences in risk factor levels,
particularly as levels of hypertension and obesity were higher in African-Americans
compared with Whites. As discussed in a previous publication, the racial difference is also
unlikely to be due to lower case ascertainment or poorer access to medical care in African-
Americans compared with whites 18. Hence, these data imply that among otherwise healthy
White individuals there are unknown risk factors, possibly genetic or other yet unknown
factors, which are important determinants of AF risk 21,24.
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In addition to the 20-year follow-up, other strengths of the study include information on a
wide range of variables to allow for adjustment, although as with any observational study it
is not possible to fully exclude the possibility of residual confounding. There are however,
some important limitations. First, we were unable to differentiate subtypes of AF and, hence,
are assuming that the associations between risk factors and outcome are consistent across
AF subtypes. This assumption is not unreasonable given that some studies, which have been
able to differentiate AF subtypes have not reported any difference in the magnitude of the
associations. For example, Dublin and colleagues observed no significant difference in the
positive relationship between diabetes and AF according to whether it was paroxysmal,
persistent or permanent 25. Second, as discussed in a previous ARIC publication 18 as cases
of AF were mainly ascertained through hospital discharge codes, this may have led to under-
ascertainment of cases that perhaps, were not severe enough to warrant hospitalization. The
third major limitation relates to possible misclassification of study participants over the
course of the follow-up period. For example, in an extreme case scenario, a participant with
AF may have had an optimal risk profile at baseline but over time, may have become obese,
hypertensive and diabetic, resulting in an elevated risk factor profile. However, as this
individual would have been classified as having an optimal profile (at baseline) this would
have resulted in an underestimation of the impact of these risk factors on subsequent risk of
AF. Third, as is common in this type of analysis we assumed censoring to be ignorable, that
is, we took into account the fact that some individuals may have died from CHD before
developing AF, by adopting the common solution to this problem, which was to adjust for
all factors that are likely causes of both AF and CHD namely hypertension, diabetes,
smoking, obesity, and heart failure, as well as age, gender and race. For this reason, we
believe our assumption that censoring is ignorable is correct to a reasonable approximation,
although it is also possible that we did not adjust for all possible factors.
Finally, as more than 98% of AF cases were diagnosed through hospital discharge forms, the
PAF’s may be more indicative of only the severest forms of AF that require hospitalization.
For example, individuals with hypertension and diabetes require more frequent medical
contact, and hence, may be more likely to have their AF detected compared with those
without these conditions and who may be asymptomatic for AF. However, in a sensitivity
analysis that included only those cases of AF diagnosed by ECG at a study visit, the results
were highly comparable with the result from the overall population. Further evidence to
support the generalizability of the study findings comes from a comparison of AF incidence
rates in ARIC with those from other population-based cohorts that were less reliant on
hospitalized records for diagnosis of AF. For example, in Framingham, the incidence rates
for AF per 1000 person-years in men and women aged 55-64 years were 6.2 and 3.8,
respectively, which are compatible with the incidence rates reported here.13 Moreover, and
importantly, the population diversity in ARIC is greater than in previous cohorts comprising
as it does individuals from four states in the United States and a significant proportion of
African-Americans.
In summary, findings from this well-characterized cohort of middle-aged men and women
indicate that maintaining an optimal risk profile would theoretically avoid more than half of
the overall burden of AF. This study further reinforces the need for successful primary
prevention strategies that enable individuals to adopt and maintain healthy diet and
behavioral patterns as a means of reducing future cardiovascular risk.
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This study, which is based on more than 17 years follow-up in over 14,500 men and
women, represents an important contribution to the literature on the major and modifiable
causes of atrial fibrillation (AF). AF is an important risk factor for stroke and overall
mortality and affects between 0.4 to 1.0% of the US population AF. Unlike other forms
of cardiovascular disease, information about the preventable burden of AF is lacking. The
aim of this study therefore was to determine what proportion of the burden of AF in
African-Americans and whites could theoretically be avoided by the maintenance of an
optimal risk profile. Previously established modifiable AF risk factors, namely high
blood pressure, elevated body mass index, diabetes, cigarette smoking and prior cardiac
disease were categorized into ‘optimal’, ‘borderline’ and ‘elevated’ levels. Based on their
risk factor levels, individuals were classified into one of these three groups. Overall, 57%
of AF cases could be explained by having one or more elevated risk factors, of which
sub-optimal blood pressure was the most important contributor accounting for one-
quarter of the burden of AF. In comparison, only 3% of AF cases were attributable to
diabetes. These findings illustrate that, as with other forms of cardiovascular disease,
more than half of the AF burden is potentially avoidable through the maintenance of
optimal levels of classical cardiovascular risk factors, further reinforcing the need for
effective primary prevention strategies that enable individuals to adopt and maintain
healthy diet and behavioral patterns.
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Survival curves adjusted for age, study center, education and height showing time free from
atrial fibrillation according to risk factor group (Optimal, Borderline or Elevated) in White
women (1A), White men (1B), African-American women (1C) and African-American men
(1D). The number of subjects at risk throughout the duration of study follow-up are shown
on the x-axis.
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